At the time of EC diagnosis and in contrast to CA125 and HE4, DJ1 and L1CAM serum levels did not correlate with disease stage, histological type or risk of disease recurrence, leaving us unable to assess their prognostic significance in patients with endometrial cancer based on the limited pilot study cohort. The gene discussed is PARK7; the disease is endometrial cancer.